A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies

Obtaining reliable longitudinal information about everyday functioning from individuals with Parkinson's disease (PD) in natural environments is critical for clinical care and research. Despite advances in mobile health technologies, the implementation of digital outcome measures is hindered by a lack of consensus on the type and scope of measures, the most appropriate approach for data capture (eg, in clinic or at home), and the extraction of timely information that meets the needs of patients, clinicians, caregivers, and health care regulators. The Movement Disorder Society Task Force on Technology proposes the following objectives to facilitate the adoption of mobile health technologies: (1) identification of patient‐centered and clinically relevant digital outcomes; (2) selection criteria for device combinations that offer an acceptable benefit‐to‐burden ratio to patients and that deliver reliable, clinically relevant insights; (3) development of an accessible, scalable, and secure platform for data integration and data analytics; and (4) agreement on a pathway for approval by regulators, adoption into e‐health systems and implementation by health care organizations. We have developed a tentative roadmap that addresses these needs by providing the following deliverables: (1) results and interpretation of an online survey to define patient‐relevant endpoints, (2) agreement on the selection criteria for use of device combinations, (3) an example of an open‐source platform for integrating mobile health technology output, and (4) recommendations for assessing readiness for deployment of promising devices and algorithms suitable for regulatory approval. This concrete implementation guidance, harmonizing the collaborative endeavor among stakeholders, can improve assessments of individuals with PD, tailor symptomatic therapy, and enhance health care outcomes. © 2019 International Parkinson and Movement Disorder Society

[1]  Holger Fröhlich,et al.  From hype to reality: data science enabling personalized medicine , 2018, BMC Medicine.

[2]  Kenneth D. Mandl,et al.  A 21st-Century Health IT System - Creating a Real-World Information Economy. , 2017, The New England journal of medicine.

[3]  A. Espay,et al.  A Viewpoint on Wearable Technology-Enabled Measurement of Wellbeing and Health-Related Quality of Life in Parkinson’s Disease , 2016, Journal of Parkinson's disease.

[4]  Günther Deuschl,et al.  MDS research criteria for prodromal Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[5]  Walter Maetzler,et al.  Participatory design in Parkinson's research with focus on the symptomatic domains to be measured. , 2015, Journal of Parkinson's disease.

[6]  Max A. Little,et al.  Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease , 2017, PloS one.

[7]  Suchi Saria,et al.  Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity: The Mobile Parkinson Disease Score , 2018, JAMA neurology.

[8]  Boo Johansson,et al.  Self-reported activities of daily living and performance-based functional ability: a study of congruence among the oldest old , 2011, European journal of ageing.

[9]  Anirvan Ghosh,et al.  Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial , 2018, Movement disorders : official journal of the Movement Disorder Society.

[10]  J. Eberling,et al.  A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein , 2018, Journal of Parkinson's disease.

[11]  A. Fasano,et al.  Technology-based assessment of motor and nonmotor phenomena in Parkinson disease , 2018, Expert review of neurotherapeutics.

[12]  Isaac S Kohane,et al.  Time for a Patient-Driven Health Information Economy? , 2016, The New England journal of medicine.

[13]  D. Heldman,et al.  Clinician versus machine: reliability and responsiveness of motor endpoints in Parkinson's disease. , 2014, Parkinsonism & related disorders.

[14]  Geraint Rees,et al.  Clinically applicable deep learning for diagnosis and referral in retinal disease , 2018, Nature Medicine.

[15]  Max A. Little,et al.  Technology in Parkinson's disease: Challenges and opportunities , 2016, Movement disorders : official journal of the Movement Disorder Society.

[16]  Ahmed Al-Jawad,et al.  A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson’s disease , 2016, Journal of NeuroEngineering and Rehabilitation.

[17]  Carlo Alberto Artusi,et al.  Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases. , 2018, Parkinsonism & related disorders.

[18]  Alan Godfrey,et al.  Ambulatory activity in incident Parkinson’s: more than meets the eye? , 2013, Journal of Neurology.

[19]  Jeffrey M. Hausdorff,et al.  Gait alterations in healthy carriers of the LRRK2 G2019S mutation , 2011, Annals of neurology.